The question big pharma has to ask themselves is what value (buy out price) before IGNITE 2 or after? If they wait until after the price goes up........a lot
Would you like to predict the outcome of their BLA this year. I actually placed a significant bet and will be happy with the outcome. That bet was placed a while back at 6 bucks, and having sold a little less than 20% of that at 43 some two years back they are paid for long held shares. I don't need to trade in and out like you to make rent. Just like here I bought the technology, and I will stick with that bet until it plays out in trials, or as an MnA. My largest investment this year (bet) was on TTPH, bought at 9, now 36ish. Once again I bought earlier in trials (ph 2 data) based on early trial data and the chemistry of their synthetic antibiotics platform. I will hold until they get bought out as well, and I expect that some time this year. I expect something in the 50/share range.
I do have some losers I still hold (IMUC and ONTY for immunotherapy plays). but the last 2-3 years have been pretty good.
My agenda is to not allow the false expectations of swing trading jackwads to effect the real valuation of the company. And thus the combined statement that I do expect a smashing success. The question has always been when will the news come out about that, the phase I study and the anticipated funding news. The amateurs here (you appear to want to be on that list as well) all want this done in ten minutes and in the end these false actually hurt the company as they try to build value. And thus the setting of false expectations by swing traders looking for an extra few pennies to make rent.
If in fact you made this downer comment based on the above post about their likely success, then you are a total and complete idiot. Builing value is not supporting swing traders. It is hitting milestones on commercial products like RSV and Flu. Now let's allow the professionals to do their job. Neither you nor birdy/lobo loser etc are on that list.
After sufficient interaction on a number of subjects and with a couple of your other IDs, I am not certain/doubtful that you actually did get that grade 1 diploma.
As to the weekend car I have been looking for something classic and convertible, maybe an older 280.
For now I am done playing with children however. Your assignment is go back to nov/dec and read about what was actually said (as opposed to the revisionist history you specialize in) and why. It will be helpful as you can now see the ebola program play out exactly as predicted with regard to announcements and timelines.
By the way the number I have posted repeatedly has been 10-12/share. Which will be 5 or 6 bagger for me. And as previously noted adequate for a new car for the weekends.
Just remember that any bid will go to shareholders for a proxy. Don't be so sure that a majority won't vote in favor of a bid well below what you think is appropriate. And make sure you add in the secondary offering that will be required to get the RSV/Flu programs to the final door. Flame away but that is what comes next
Bull top to bottom. What can't be believed is the pumping BS out of three or four of the IDs here that like to make sh--t up.
You can reject actual industry knowledge or you could listen, write it down and learn something.
You are well known for diligence I see (that is the joke here). But since I was VP development for IDB for 8 years I guess I would know what they were worth, and by extension NVAX. What they had was an FDA inspected production plant capable of making up to 90M doses of flu vaccine a year, and a 300m contract for pandemic flu production from US gov. Add in contracts for plague, anthrax and the unique group A strep vaccine (was in ph2) and it was the largest pure vaccine acquisition ever done. Ask a couple of the senior VPs at NVAX, that where they came from.
The rest of your laughable paranoid rant is just that, cuz stupid has a name, and it's yours.
Paid for with profits from sales at 43 two years ago, cost ave at just over 6. Plus banked profit. So what. Cost ave here at 2. I don't invest to swing trade like you do I invest long term and don't cry like a child when you don't understand why primate study result isnt letting you make an extra quarter while youa 'lighten up a bit' to make your rent this month. Take a breath and gather yourself.
The response I posted for this BS appeared above and seems out of place, so here it is in it's proper place.
Now try and read what was actually said about ebola and stop making a fool of yourself. Delusional revisionist history at best. A child is more like it. Grow up, people are laughing at you.
And lets add an extra line. Ideas? Creativity in this business? List your patents and publications and let's talk about creativity and where it belongs. Now go make me a nice sandwich you sad little tool.
I, like you have no idea.
I repeat again for the 50th time (dating back to when you think I opposed an Ebola project) shut up and let them do their job. Creativity in public relations and PR is for hacks like you that don't understand the real issues of running a biotech company.
Now try and read what was actually said about ebola and stop making a fool of yourself. Delusional revisionist history at best. A child is more like it. Grow up, people are laughing at you
You have no idea. Doesn't stop you from posting it over and over again. But the simple fact is you have zero info to #$%$.
I believe the primate study will be a smashing success. I will however wait for the company to do their job and release data that is mature, reviewed and ready for prime time. I still believe that this will be released at the same time as funding news....but we will see if that belief becomes a fact. I believe they have not had a PR on trial start as they understand the market does not want them spending the RSV money on ebola, and thus the downplay (appropriately so) by management. If funding news comes along with the primate results, that will be the catalyst to run up another buck. If funding is in the 10M range that is. If funding were considerable, i.e. similar to JnJ money. Then more than a buck.
Now let's allow the professionals to do their job.
Thanks Zinc. Been saying this for a couple of months now. Just let them do their job. The hype actually hurts, at least some understand that truth
Strategically Pfizer sold their flu vaccine business and have moved away from this sector. They are one big pharma that will not be making a play for NVAX
Demonstrated how? By the absence of a shred of truth in your post. Over 30 years now of top down economics have proven beyond a shadow of doubt that Reagonomics is nothing but a deceptive scam. Like you